Titre:
  • Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials).
Auteur:Bonnetain, Franck; Bonsing, Bert; Conroy, Thierry; Dousseau, Adelaide; Glimelius, Bengt; Haustermans, Karin; Lacaine, François; Van Laethem, Jean-Luc; Aparicio, Thomas; Aust, Daniela D.E.; Bassi, Claudio; Berger, Virginie; Chamorey, Emmanuel; Chibaudel, Benoist; Dahan, Laeticia; de Gramont, Aimery; Delpero, Jean Robert; Dervenis, Christos; Ducreux, Michel; Gal, Jocelyn; Gerber, Erich; Ghaneh, Paula; Hammel, Pascal; Hendlisz, Alain; Jooste, Valérie; Labianca, Roberto; Latouche, Aurelien; Lutz, Manfred B.; Macarulla, Teresa; Malka, D; Mauer, Murielle; Mitry, Emmanuel; Neoptolemos, John; Pessaux, Patrick; Sauvanet, Alain; Tabernero, Josep; Taieb, Julien; Van Tienhoven, Geertjan; Gourgou-Bourgade, Sophie; Bellera, Carine; Mathoulin-Pélissier, Simone; Collette, Laurence
Informations sur la publication:European journal of cancer, 50, 17, page (2983-2993)
Statut de publication:Publié, 2014-11
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Clinical trials
Consensus
Guidelines
Methodology
Pancreatic cancer
Time to event end-point
MeSH keywords:Consensus
Delphi Technique
Disease-Free Survival
Endpoint Determination
Humans
Pancreatic Neoplasms -- mortality -- therapy
Randomized Controlled Trials as Topic
Note générale:SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2014.07.011
info:pii/S0959-8049(14)00811-9
info:scp/84925237877
info:pmid/25256896